Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy
Sponsored by Johns Hopkins University
About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 3 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Diagnosis of PPA, based on the PPA criteria and presence of naming deficits
- Capable of giving informed consent or indicating another to provide informed consent
- 18 years of age to 100 years of age..
Exclusion Criteria
- Did not speak English before the age of five
- Less than 10 years of education
- Severe naming deficits
- Significant history of drug or alcohol abuse
- History of psychiatric or neurological problems affecting the brain (besides PPA)
- Has experienced seizures during the previous 12 months
- History of brain surgery or any metal in the head
- Uncorrected visual loss or hearing loss by self-report
- Use of medications that lower the seizure threshold (e.g., methylphenidate) or use of N-Methyl-D-aspartate (NMDA) receptor antagonists (e.g., memantine)
- Scalp sensitivity (per participant report)